Alpha Lipoic Acid Market Trend to 2024 Profiling Now Health, HiMedia Laboratories, Sabinsa Corporation, AlzChem AG, Qidu Pharmaceutical, Infa Group

Market Study Report recently introduced new title on “2017-2024 Global Alpha Lipoic Acid Market Report” that provides an in-depth overview of industry and competitive landscape, covering multiple market segments and elaborates market outlook and status to 2024.

Alpha lipoic acid market size is positively influenced by increasing product application scope in production of medical drugs and dietary food products. Exponentially growing healthcare and pharmaceutical industry shall positively influence alpha lipoic acid market for the forecast duration. Amplified expenditure pattern of dual income family along with growing preference for dietary food and slimming products has propelled product demand in the past few years. Alpha Lipoic Acid Market size is forecast to exceed USD 19 million by 2024; according to a new research report.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/496349/

Increasing popularity of low fat diet food and several weight loss products shall boost the overall alpha lipoic acid market in the coming years. It is an excellent antioxidant and is biologically active, thus extensively used to make drugs at a vast scale. Rising health problems and fatal diseases prevailing accompanied with increasing awareness regarding healthy lifestyle and fitness shall accelerate alpha lipoic acid market growth over the forecast timeframe. The major hurdle for future product market growth is the availability of various substitutes and some side effects caused by over dosage of product.

Dietary supplements segment held a major share of global alpha lipoic acid market in 2016. The market share will increase over the next few years owing to its widespread usage in among consumers to stay healthy and fit. Slimming products segment also had a significant share in alpha lipoic acid market in 2016 and is projected to expand at a prominent rate, approximately 5%, due to rising demand and awareness pertaining to personal care and fitness among consumers.

Medical drugs application is the fastest growing segment in North America and shall be witnessing significant gains in the forecast timeframe. The obesity and diabetes problems prevailing in North America are some key factors that have been driving the product sales in this region in past few years. The product is widely used in drugs utilized for treatment of various diseases such as liver ailment, cancer, skin disorder, cataract formation, diabetes, etc.

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/496349/

Asia Pacific for alpha lipoic acid market shall witness gains more than 7% during the forecast timespan. It is due to the developing economic conditions, which have considerably improved the healthcare industry in recent times and have eventually fueled alpha lipoic acid demand in recent times. Asia Pacific, both in terms of volume and value, shall be leading the global alpha lipoic market over the forecast timespan. Shifting of pharmaceutical manufacturing units to countries including India and China shall generate heavy revenue for the industry during the forecast period.

Europe followed Asia Pacific in terms of revenue in 2016 and had significant market share in the same year. Higher penetration of online business in Europe has resulted in propelling the alpha lipoic acid market for medical drugs production in this region. Middle East & Africa and Latin America are forecast to witness significant growth, close to 6%, by 2024. This can be attributed to its developing pharmaceutical industry and rising demand for dietary and slimming food products.

The alpha lipoic acid market is fairly competitive. Key product manufacturers are Now Health, HiMedia Laboratories, Sabinsa Corporation, AlzChem AG, Qidu Pharmaceutical and Infa Group. Other prominent market share contributors are Swanson Health Inc., Cambridge Commodities Limited, Toyo Hakko Company Limited and Shanghai Shyndec (Modern) Pharmaceutical Company Limited.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Definitions & forecast parameters
1.2. Data sources
1.2.1. Primary
1.2.2. Secondary

Chapter 2. Executive Summary
2.1. Alpha lipoic acid industry 360° synopsis, 2013 – 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Regional trends

Chapter 3. Alpha Lipoic Acid Industry Insights
3.1. Industry segmentation
3.2. Industry size and forecast, 2013 - 2024
3.3. Industry ecosystem analysis
3.3.1. Vendor matrix
3.3.2. Distributor channel analysis
3.4. Industry impact forces
3.4.1. Growth drivers
3.4.1.1. Improving health standards in Asia Pacific
3.4.1.2. Robust product demand for medical applications in North America
3.4.2. Industry pitfalls & challenges
3.4.2.1. Limited product use due to its side effects
3.4.2.2. Availability of several product substitutes
3.5. Regulatory landscape
3.5.1. U.S.
3.5.2. Europe
3.5.3. China
3.6. Growth potential analysis
3.7. Porter’s analysis
3.8. Company market share analysis, 2016
3.8.1. Strategy landscape
3.9. PESTEL analysis
3.10. Regional price trends

For more information on this report, Please visit at: https://www.marketstudyreport.com/reports/alpha-lipoic-acid-market/?utm_source=OPR-SP

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.